Par-4, a pro-apoptotic gene, inhibits radiation-induced NFκB activity and Bcl-2 expression leading to induction of radiosensitivity in human prostate cancer cells PC-3

Cancer Biology and Therapy

Volumn 1, Issue 2, 2002, Pages 152-160

  Chendil, Damodaran ^a   Das, Anindita ^a   Dey, Swatee ^a   Mohiuddin, Mohammed ^a,b   Ahmed, Mansoor M ^a,b,c  

^a UNIVERSITY OF KENTUCKY   (United States)

^b UNIVERSITY OF KENTUCKY   (United States)

^c UNIVERSITY OF KENTUCKY   (United States)

Author keywords

Bcl 2; NF B; Par 4; Prostate cancer; Radiation sensitivity

Indexed keywords

APOPTOSIS REGULATORY PROTEIN; CARRIER PROTEIN; DNA BINDING PROTEIN; I KAPPA B; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; NF KAPPAB INHIBITOR ALPHA; NF-KAPPAB INHIBITOR ALPHA; PROSTATE APOPTOSIS RESPONSE 4 PROTEIN; PROSTATE APOPTOSIS RESPONSE-4 PROTEIN; PROTEIN BCL 2; SIGNAL PEPTIDE;

APOPTOSIS; ARTICLE; CELL CULTURE; DRUG ANTAGONISM; GENE EXPRESSION REGULATION; GENETICS; HUMAN; MALE; METABOLISM; PATHOLOGY; PHOSPHORYLATION; PROSTATE TUMOR; RADIATION DOSE; RADIATION EXPOSURE; UPREGULATION;

APOPTOSIS; APOPTOSIS REGULATORY PROTEINS; CARRIER PROTEINS; DNA-BINDING PROTEINS; GENE EXPRESSION REGULATION; HUMANS; I-KAPPA B PROTEINS; INTRACELLULAR SIGNALING PEPTIDES AND PROTEINS; MALE; NF-KAPPA B; PHOSPHORYLATION; PROSTATIC NEOPLASMS; PROTO-ONCOGENE PROTEINS C-BCL-2; RADIATION TOLERANCE; TUMOR CELLS, CULTURED; UP-REGULATION;

EID: 0036491706     PISSN: 15384047     EISSN: 15558576     Source Type: Journal    
DOI: 10.4161/cbt.61     Document Type: Article

References (58)

1. Fornace AJ, Jr., Amundson SA, Bittner M, Myers TG, Meltzer P, Weinsten JN, et al. The complexity of radiation stress responses: analysis by informatics and functional genomics approaches. Gene Expr 1999; 7:387-400. (Pubitemid 29372082)
2. MacCallum DE, Hupp TR. Induction of p53 protein as a marker for ionizing radiation exposure in vivo. Methods Mol Biol 1999; 113:583-9.
3. McKenzie PP, Guichard SM, Middlemas DS, Ashmun RA, Danks MK, Harris LC. Wild-type p53 can induce p21 and apoptosis in neuroblastoma cells but the DNA damage-induced G1 checkpoint function is attenuated. Clin Cancer Res 1999; 5:4199-207. (Pubitemid 30013806)
4. Nakamura Y, Hasegawa M, Hayakawa K, Matsuura M, Suzuki Y, Nasu S, et al. Induction of p53-dependent apoptosis in vivo by nedaplatin and ionizing radiation. Oncol Rep 2000; 7:261-65.
5. Ahmed MM, Venkatasubbarao K, Fruitwala SM, Muthukkumar S, Wood DP, Jr., Sells SF, et al. EGR-1 induction is required for maximal radiosensitivity in A375-C6 melanoma cells. J Biol Chem 1996; 271:29231-7. (Pubitemid 26382635)
6. Chen M, Quintans J, Fuks Z, Thompson C, Kufe DW, Weichselbaum RR. Suppression of Bcl-2 messenger RNA production may mediate apoptosis after ionizing radiation, tumor necrosis factor alpha, and ceramide. Cancer Res 1995; 55:991-4.
7. Q, Kontny U, Iglesias M, Alamo I, Jr., Yu K, Hollander MC, et al. Inhibitory effect of Bcl-2 on p53-mediated transactivation following genotoxic stress. Oncogene 1999; 18:297-304. (Pubitemid 29060605)
8. Miyashita T, Reed JC. Tumor suppressor p53 is a direct transcriptional activator of the human bax gene. Cell 1995; 80:293-9.
9. Strobel T, Swanson L, Korsmeyer S, Cannistra SA. Radiation-induced apoptosis is not enhanced by expression of either p53 or BAX in SW626 ovarian cancer cells. Oncogene 1997; 14:2753-8. (Pubitemid 27313406)
10. Reed JC. Bcl-2 family proteins. Oncogene 1998; 17:3225-36. (Pubitemid 29043975)
11. Knudson CM, Korsmeyer SJ. Bcl-2 and Bax function independently to regulate cell death. Nat Genet 1997; 16:358-63. (Pubitemid 27323300)
12. St. Clair EG, Anderson SJ, Oltvai ZN. Bcl-2 counters apoptosis by Bax heterodimerization-dependent and - independent mechanisms in the T-cell lineage. J Biol Chem 1997; 272:29347-55. (Pubitemid 27498229)
13. Ishibashi Y, Nishimaki K, Asoh S, Nanbu-Wakao R, Yamada T, Ohta S. Pore formation domain of human pro-apoptotic Bax induces mammalian apoptosis as well as bacterial death without antagonizing anti- apoptotic factors. Biochem Biophys Res Commun 1998; 243:609-16. (Pubitemid 28414072)
14. Miyashita T, Harigai M, Hanada M, Reed JC. Identification of a p53-dependent negative response element in the bcl- 2 gene. Cancer Res 1994; 54:3131-5. (Pubitemid 24208916)
15. Tamatani M, Che YH, Matsuzaki H, Ogawa S, Okado H, Miyake S, et al. Tumor necrosis factor induces Bcl-2 and Bcl-x expression through NFkappaB activation in primary hippocampal neurons. J Biol Chem 1999; 274:8531-8. (Pubitemid 29164643)
16. Dixon EP, Stephenson DT, Clemens JA, Little SP. Bcl-Xshort is elevated following severe global ischemia in rat brains. Brain Res 1997; 776:222-9. (Pubitemid 28018478)
17. Kariya S, Ogawa Y, Yoshida S, Yabuki M, Imajo Y, Utsumi K. X-irradiation enhances the expression of Bcl-2 in HL-60 cells: The resulting effects on apoptosis and radiosensitivity. Int J Mol Med 1999; 3:145-52.
18. Sells SF, Wood DP, Jr., Joshi-Barve SS, Muthukumar S, Jacob RJ, Crist SA, et al. Commonality of the gene programs induced by effectors of apoptosis in androgen-dependent and -independent prostate cells. Cell Growth Differ 1994; 5:457-66. (Pubitemid 24251397)
19. Diaz-Meco MT, Municio MM, Frutos S, Sanchez P, Lozano J, Sanz L, et al. The product of par-4, a gene induced during apoptosis, interacts selectively with the atypical isoforms of protein kinase C. Cell 1996; 86:777-86. (Pubitemid 26303446)
20. Johnstone RW, See RH, Sells SF, Wang J, Muthukkumar S, Englert C, et al. A novel repressor, par-4, modulates transcription and growth suppression functions of the Wilms' tumor suppressor WT1. Mol Cell Biol 1996; 16:6945-56. (Pubitemid 26389754)
21. Diaz-Meco MT, Lallena MJ, Monjas A, Frutos S, Moscat J. Inactivation of the inhibitory kappaB protein kinase/nuclear factor kappaB pathway by Par-4 expression potentiates tumor necrosis factor alpha-induced apoptosis. J Biol Chem 1999; 274:19606-12.
22. Nalca A, Qiu SG, El-Guendy N, Krishnan S, Rangnekar VM. Oncogenic Ras sensitizes cells to apoptosis by Par-4. J Biol Chem 1999; 274:29976-83.
23. Qiu G, Ahmed M, Sells SF, Mohiuddin M, Weinstein MH, Rangnekar VM. Mutually exclusive expression patterns of Bcl-2 and Par-4 in human prostate tumors consistent with down-regulation of Bcl-2 by Par-4. Oncogene 1999; 18:623-31. (Pubitemid 29080319)
24. Brach MA, Hass R, Sherman ML, Gunji H, Weichselbaum R, Kufe D. Ionizing radiation induces expression and binding activity of the nuclear factor kappa B. J Clin Invest 1991; 88:691-5.
25. Sells SF, Han SS, Muthukkumar S, Maddiwar N, Johnstone R, Boghaert E, et al. Expression and function of the leucine zipper protein Par-4 in apoptosis. Mol Cell Biol 1997; 17:3823-32. (Pubitemid 27281857)
26. Ahmed MM, Sells SF, Venkatasubbarao K, Fruitwala SM, Muthukkumar S, Harp C, et al. Ionizing radiation-inducible apoptosis in the absence of p53 linked to transcription factor EGR-1. J Biol Chem 1997; 272:33056-61. (Pubitemid 28023646)
27. Batra RK, Guttridge DC, Brenner DA, Dubinett SM, Baldwin AS, Boucher RC. IkappaBalpha gene transfer is cytotoxic to squamous-cell lung cancer cells and sensitizes them to tumor necrosis factor-alpha-mediated cell death. Am J Respir Cell Mol Biol 1999; 21:238-45. (Pubitemid 129502222)
28. Persico MG, Viglietto G, Martini G, Toniolo D, Paonessa G, Moscatelli C, et al. Isolation of human glucose-6-phosphate dehydrogenase (G6PD) cDNA clones: primary structure of the protein and unusual 5′ non-coding region [published erratum appears in Nucleic Acids Res 1986 Oct 10; 14(19):7822]. Nucleic Acids Res 1986; 14:2511-22.
29. Nair P, Muthukkumar S, Sells SF, Han SS, Sukhatme VP, Rangnekar VM. Early growth response-1-dependent apoptosis is mediated by p53. J Biol Chem 1997; 272:20131-8. (Pubitemid 27340120)
30. Bradford MM. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem 1976; 72:248-54.
31. Curry HA, Clemens RA, Shah S, Bradbury CM, Botero A, Goswami P, et al. Heat shock inhibits radiation-induced activation of NF-kappaB via inhibition of I-kappaB kinase. J Biol Chem 1999; 274:23061-7.
32. Lee SJ, Dimtchev A, Lavin MF, Dritschilo A, Jung M. A novel ionizing radiation-induced signaling pathway that activates the transcription factor NF-kappaB. Oncogene 1998; 17:1821-6. (Pubitemid 28482785)
33. Thanos D, Maniatis T. NF-kappa B: a lesson in family values. Cell 1995; 80:529-32.
34. Baldwin AS, Jr. The NF-kappa B and I kappa B proteins: new discoveries and insights. Annu Rev Immunol 1996; 14:649-83.
35. Verma IM, Stevenson JK, Schwarz EM, Van Antwerp D, Miyamoto S. Rel/NF-kappa B/I kappa B family: intimate tales of association and dissociation. Genes Dev 1995; 9:2723-35. (Pubitemid 3009952)
36. Chen L, Fischle W, Verdin E, Greene WC. Duration of nuclear NF-kappaB action regulated by reversible acetylation. Science 2001; 293:1653-7. (Pubitemid 32807844)
37. Weichselbaum RR, Hallahan D, Fuks Z, Kufe D. Radiation induction of immediate early genes: effectors of the radiation-stress response. Int J Radiat Oncol Biol Phys 1994; 30:229-34. (Pubitemid 24291134)
38. Li N, Karin M. Ionizing radiation and short wavelength UV activate NF-kappaB through two distinct mechanisms. Proc Natl Acad Sci U S A 1998; 95:13012-7. (Pubitemid 28509515)
39. Baeuerle PA, Henkel T. Function and activation of NF-kappa B in the immune system. Annu Rev Immunol 1994; 12:141-79.
40. Gius D, Cao XM, Rauscher FJd, Cohen DR, Curran T, Sukhatme VP. Transcriptional activation and repression by Fos are independent functions: the C terminus represses immediate-early gene expression via CArG elements. Mol Cell Biol 1990; 10:4243-55.
41. Beg AA, Baltimore D. An essential role for NF-kappaB in preventing TNF-alpha-induced cell death [see comments]. Science 1996; 274:782-4. (Pubitemid 26398258)
42. Bertrand F, Atfi A, Cadoret A, L'Allemain G, Robin H, Lascols O, et al. A role for nuclear factor kappaB in the antiapoptotic function of insulin. J Biol Chem 1998; 273:2931-8. (Pubitemid 28133944)
43. Horvai AE, Xu L, Korzus E, Brard G, Kalafus D, Mullen TM, et al. Nuclear integration of JAK/STAT and Ras/AP-1 signaling by CBP and p300. Proc Natl Acad Sci U S A 1997; 94:1074-9. (Pubitemid 27087806)
44. Klefstrom J, Arighi E, Littlewood T, Jaattela M, Saksela E, Evan GI, et al. Induction of TNF-sensitive cellular phenotype by c-Myc involves p53 and impaired NF-kappaB activation. Embo J 1997; 16:7382-92. (Pubitemid 28010498)
45. Liu ZG, Hsu H, Goeddel DV, Karin M. Dissection of TNF receptor 1 effector functions: JNK activation is not linked to apoptosis while NF-kappaB activation prevents cell death. Cell 1996; 87:565-76. (Pubitemid 26374329)
46. Wang CY, Mayo MW, Baldwin AS, Jr. TNF- and cancer therapy-induced apoptosis: potentiation by inhibition of NF-kappaB [see comments]. Science 1996; 274:784-7. (Pubitemid 26398259)
47. Van Antwerp DJ, Martin SJ, Kafri T, Green DR, Verma IM. Suppression of TNF-alpha-induced apoptosis by NF-kappaB [see comments]. Science 1996; 274:787-9.
48. Wu M, Lee H, Bellas RE, Schauer SL, Arsura M, Katz D, et al. Inhibition of NF-kappaB/Rel induces apoptosis of murine B cells. Embo J 1996; 15:4682-90. (Pubitemid 26294586)
49. Wang CY, Guttridge DC, Mayo MW, Baldwin AS, Jr. NF-kappaB induces expression of the Bcl-2 homologue A1/Bfl-1 to preferentially suppress chemotherapy-induced apoptosis. Mol Cell Biol 1999; 19:5923-9.
50. Kroger LA, DeNardo SJ, DeNardo GL, Xiong CY, Winthrop MD, Gumerlock PH. Effect of 67Cu-2IT-BAT-Lym-1 therapy on BCL-2 gene and protein expression in a lymphoma mouse model. Clin Cancer Res 1999; 5:3010s-14s.
51. Kroger LA, DeNardo GL, Gumerlock PH, Xiong CY, Winthrop MD, Shi XB, et al. Apoptosis-related gene and protein expression in human lymphoma xenografts (Raji) after low dose rate radiation using 67Cu-2IT-BAT-Lym-1 radioimmunotherapy. Cancer Biother Radiopharm 2001; 16:213-25. (Pubitemid 32641219)
52. Mackey TJ, Borkowski A, Amin P, Jacobs SC, Kyprianou N. bcl-2/bax ratio as a predictive marker for therapeutic response to radiotherapy in patients with prostate cancer. Urology 1998; 52:1085-90. (Pubitemid 28533381)
53. Kyprianou N, King ED, Bradbury D, Rhee JG. bcl-2 over-expression delays radiation-induced apoptosis without affecting the clonogenic survival of human prostate cancer cells. Int J Cancer 1997; 70:341-8. (Pubitemid 27099605)
54. Hockenbery D, Nunez G, Milliman C, Schreiber RD, Korsmeyer SJ. Bcl-2 is an inner mitochondrial membrane protein that blocks programmed cell death. Nature 1990; 348:334-6. (Pubitemid 120029101)
55. Sentman CL, Shutter JR, Hockenbery D, Kanagawa O, Korsmeyer SJ. bcl-2 inhibits multiple forms of apoptosis but not negative selection in thymocytes. Cell 1991; 67:879-88. (Pubitemid 121001502)
56. Berra E, Municio MM, Sanz L, Frutos S, Diaz-Meco MT, Moscat J. Positioning atypical protein kinase C isoforms in the UV-induced apoptotic signaling cascade. Mol Cell Biol 1997; 17:4346-54. (Pubitemid 27318111)
57. Camandola S, Mattson MP. Pro-apoptotic action of PAR-4 involves inhibition of NF-kappaB activity and suppression of BCL-2 expression. J Neurosci Res 2000; 61:134-9. (Pubitemid 30451800)
58. Pajonk F, Pajonk K, McBride WH. Inhibition of NF-kappaB, clonogenicity, and radiosnsitivity of human cancer cells. J Natl Cancer Inst 1999; 91:1956-60.